EMBC — Embecta Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSuper Stock

Annual income statement for Embecta, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,086	1,165	1,130	1,121	1,123
Cost of Revenue
Gross Profit	763	800	775	750	735
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	599	673	820	899	956
Operating Profit	487	492	310	222	167
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	486	495	257	106	44.2
Provision for Income Taxes
Net Income After Taxes	428	415	224	70.4	78.3
Net Income Before Extraordinary Items
Net Income	428	415	224	70.4	78.3
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	428	415	224	70.4	78.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	7.4	7.17	5.51	2.32	2.66
Dividends per Share